Breast Cancer

Medullary breast cancers are not an indication for BRCA1 mutation screening

Published in Medical Devices and Surgical Technology Week, May 30th, 2004

Research suggests that medullary breast cancers, independent of family risk factors, are not an indication for BRCA1 mutation screening.

"Recommended guidelines have limited breast cancer gene (BRCA1) mutation testing to individuals with a personal or family history of early onset breast and/or ovarian cancer, and those with multiple affected close relatives. Such large breast cancer families are rare in the general population, limiting the clinical application of the BRCA1 discovery," scientists writing in the journal Breast Cancer Research and Treatment report.

"Previous reports have suggested an association between medullary breast cancer...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week

Source: Medical Devices and Surgical Technology Week (2004-05-30)

More Articles from Medical Devices and Surgical Technology Week

Anesthesiology
Cuffed oropharyngeal airway device useful in awake cranial surgery
Breast Cancer Diagnostics
Tissue microarray valuable for validation of HER2 FISH testing
Heart Surgery
Novel cryoprobe shows promise for intraoperative AF treatment
Ophthalmology
Self-lit contact lens for peripheral vitreous surgery developed
Orthopedic Surgery
Abrasive water jet osteotomy lacks deleterious thermal effect
Addiction Research
New study to ask: Will early lung cancer detection lead to tobacco cessation?
More from this issue of Medical Devices and Surgical Technology Week

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry